Radiation safety program for the cardiac catheterization laboratory.
The Society of Cardiovascular Angiography and Interventions present a practical approach to assist cardiac catheterization laboratories in establishing a radiation safety program. The importance of this program is emphasized by the appropriate concerns for the increasing use of ionizing radiation in medical imaging, and its potential adverse effects. An overview of the assessment of radiation dose is provided with a review of basic terminology for dose management. The components of a radiation safety program include essential personnel, radiation monitoring, protective shielding, imaging equipment, and training/education. A procedure based review of radiation dose management is described including pre-procedure, procedure and post-procedure best practice recommendations. Specific radiation safety considerations are discussed including women and fluoroscopic procedures as well as patients with congenital and structural heart disease.
Pennsylvania State University College of Medicine, MS Hershey Medical Center, Hershey, Pennsylvania, USA. cchambers@psu.edu
Charles E
CE
Chambers
Kenneth A
KA
Fetterly
Ralf
R
Holzer
Pei-Jan Paul
PJ
Lin
James C
JC
Blankenship
Stephen
S
Balter
Warren K
WK
Laskey
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000193:education; D019985:Benchmarking; D006328:Cardiac Catheterization / Q000009:adverse effects*; D017023:Coronary Angiography / Q000009:adverse effects; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007753:Laboratories / Q000458:organization & administration; D008297:Male; D009784:Occupational Diseases / Q000209:etiology / Q000517:prevention & control*; D016273:Occupational Exposure; D009937:Organizational Objectives; D017410:Practice Guidelines as Topic; D016730:Program Development; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000209:etiology / Q000517:prevention & control*; D011835:Radiation Protection / Q000379:methods*; D015641:Radiography, Interventional / Q000009:adverse effects; D018570:Risk Assessment; D012955:Societies, Medical